Using Generalized Anxiety Disorder-2 (GAD-2) and GAD-7 in a Primary Care Setting.
anxiety
general & adult psychiatry
generalized anxiety disorder
generalized anxiety disorder questionnaire
mental health
mental health screening
mental health services
primary care
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
21 May 2020
21 May 2020
Historique:
entrez:
26
6
2020
pubmed:
26
6
2020
medline:
26
6
2020
Statut:
epublish
Résumé
Anxiety disorders are highly prevalent in the primary care setting and are responsible for significant morbidity as well as a loss of productivity. Evaluation by mental health specialists and behavioral specialists can sometimes be confounded with problems of availability, accessibility, and the patient's hesitancy to talk to new providers due to lack of prior relationship and trust. Primary care providers already have the advantage of being available for their patients, and have built years of trust behind them to strengthen this relationship. The biggest problems which confront primary care are the time constraints as well as the presence of multiple medical demands. This leads to a constant need for tools that facilitate early recognition and diagnosis of mental health disorders while also providing judicious utilization of clinic time. This article attempts to review the use of two of these popular tools: Generalized Anxiety Disorder scale-2 (GAD-2) and GAD-7 in the primary care setting.
Identifiants
pubmed: 32582485
doi: 10.7759/cureus.8224
pmc: PMC7306644
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e8224Informations de copyright
Copyright © 2020, Sapra et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Nord J Psychiatry. 2018 Feb;72(2):112-118
pubmed: 29105551
Fam Pract. 2016 Feb;33(1):112-7
pubmed: 26546033
Proc Annu Meet Am Psychopathol Assoc. 1976;(64):178-218
pubmed: 772673
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Dialogues Clin Neurosci. 2003 Jun;5(2):115-28
pubmed: 22034245
Psychiatry Res. 2017 Oct;256:312-317
pubmed: 28666201
Scand J Prim Health Care. 2014 Jun;32(2):78-83
pubmed: 24920316
J Clin Psychiatry. 2001;62 Suppl 11:15-9; discussion 20-1
pubmed: 11414546
Ann Intern Med. 2007 Mar 6;146(5):317-25
pubmed: 17339617
Health Qual Life Outcomes. 2012 Sep 19;10:114
pubmed: 22992432
J Pak Med Assoc. 2017 Oct;67(10):1536-1540
pubmed: 28955070
Br J Psychiatry. 1982 Nov;141:518-23
pubmed: 7150890
Psychopharmacol Ser. 1990;9:72-9
pubmed: 2204923
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Shanghai Arch Psychiatry. 2014 Aug;26(4):227-31
pubmed: 25317009
Gen Hosp Psychiatry. 2016 Mar-Apr;39:24-31
pubmed: 26719105
PLoS One. 2017 Aug 3;12(8):e0182162
pubmed: 28771530
Med Care. 2008 Mar;46(3):266-74
pubmed: 18388841